Introduction: Uterine fibroids are the most common gynecological tumors in women of
childbearing age and have multiple clinical manifestations. Objective: To determine factors associated with uterine fibroids in the Borgou department
of Benin in 2022. Method: Descriptive, analytical cross-sectional study
from August 22 to September 22, 2022. The sample consisted of women consulting
for gynecological problems in 6 hospitals in the Borgou department in the North
of Benin. Results: Of the 744 women surveyed, 10.1% were diagnosed with uterine
fibroids. Women with uterine fibroids were often married, paucigesture, and
nulliparous. Their main reasons for consultation were the desire for motherhood
(50.7%), pelvic pain (46.7%), and genital hemorrhage (14.7%). Age, history of
miscarriage, high blood pressure, and diabetes were significantly associated
with the presence of uterine fibroids (<0.0001). Conclusion: Uterine
fibroids are common in hospitals in northern Benin. There were factors
associated with them that should be taken into account in management
strategies.
References
[1]
Stewart, E.A., Laughlin-Tommaso, S.K. and Catherino, W.H. (2017) Epidemiology of Uterine Fibroids: A Systematic Review. BJOG, 124, 1501-1512.
https://doi.org/10.1111/1471-0528.14640
[2]
Rongières, C. (1999) Epidemiology of Uterine Fibroma: Risk Factors and Frequency. Impact on Public Health. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 28, 701-706.
[3]
Faerstein, E., Szklo, M. and Rosenshein, N. (2001) Risk Factors for Uterine Leiomyoma: A Practice-Based Case-Control Study. I. African-American Heritage. Reproductive History, Body Size, and Smoking. American Journal of Epidemiology, 153, 1-10. https://doi.org/10.1093/aje/153.1.1
[4]
Racinet, C. (2009) épidémiologie, facteurs de risque et symptomatologie des myomes utérins. Médecine de la Reproduction, 11, 118-122.
[5]
Poncelet, C., Benifla, J.L., Batallan, A., Darai, E. and Madelenat, P. (2001) Myome et infertilité: Analyse de la littérature. Gynécologie Obstétrique & Fertilité, 29, 413-421. https://doi.org/10.1016/S1297-9589(01)00154-0
[6]
Fernandez, H., Chabbert Buffet, N. and Allouche, S. (2014) Prévalence du fibrome utérin en France et impact sur la qualité de vie à partir d’une enquête menée auprès de 2500 femmes de 30–55ans. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 43, 721-727. https://doi.org/10.1016/j.jgyn.2014.07.006
[7]
Zimmermann, A., Bernuit, D., Gerlinger, C., Schaefers, M. and Geppert, K. (2012) Prevalence, Symptoms and Management of Uterine Fibroids: An International Internet-Based Survey of 21,746 Women. BMC Women’s Health, 12, Article No.6.
https://doi.org/10.1186/1472-6874-12-6
[8]
Dembele, S., Diassana, M., Macalou, B., Sidibe, A., Hamidou, A. and Doumbia, F. (2023) Aspects épidémiocliniques et thérapeutiques du fibrome utérin à l’hopital Fousseyni Daou de Kayes. Health Sciences and Disease, 24, 107-111.
[9]
The Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society of Reproductive Surgeons (2008) Myomas and Reproductive Function. Fertility and Sterility, 90, S125-S130.
https://doi.org/10.1016/j.fertnstert.2008.09.012
[10]
Pritts, E.A., Parker, W.H. and Olive, D.L. (2009) Fibroids and Infertility: An Updated Systematic Review of the Evidence. Fertility and Sterility, 91, 1215-1223.
[11]
Tiemtoré-Kambou, B.M.A., Baguiya, A., Lamien, P.D., Koama, A., Napon, A.M. and Bamouni, Y.A. (2021) Myome, découverte fortuite ou métrorragie: qui dit mieux? The Pan African Medical Journal, 38, Article 388.
https://doi.org/10.11604/pamj.2021.38.388.20314
[12]
Balungwe, S., Maroyi, R., Joyeux, M., Omari, M., Philémon, M. and Olivier, N. (2021) Epidemiological Aspects of Uterine Myomas among Nulligest Women at the General Reference Hospital of Panzi in Democratic Republic of the Congo. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 10, 1759-1762. https://doi.org/10.18203/2320-1770.ijrcog20211486
[13]
Wise, L.A., Palmer, R., Stewart, A. and Rosenberg, L. (2005) Age-Specific Incidence Rates for Self-Reported Uterine Leiomyomata in the Black Women’s Health Study. Obstetrics & Gynecology, 105, 563-568.
https://doi.org/10.1097/01.AOG.0000154161.03418.e3
[14]
Day Baird, D., Dunson, D.B., Hill, M.C., Cousins, D. and Schectman, J.M. (2003) High Cumulative Incidence of Uterine Leiomyoma in Black and White Women: Ultrasound Evidence. American Journal of Obstetrics and Gynecology, 188, 100-107. https://doi.org/10.1067/mob.2003.99
[15]
Boynton-Jarrett, R. (2005) A Prospective Study of Hypertension and Risk of Uterine Leiomyomata. American Journal of Epidemiology, 161, 628-638.
https://doi.org/10.1093/aje/kwi072
[16]
Wise, L.A., Palmer, J.R., Spiegelman, D., Harlow, B.L., Stewart, E.A. and Adams- Campbell, L.L. (2005) Influence of Body Size and Body Fat Distribution on Risk of Uterine Leio-myomata in U.S. Black Women. Epidemiology, 16, 346-354.
https://doi.org/10.1097/01.ede.0000158742.11877.99
[17]
Klatsky, P.C., Tran, N.D., Caughey, A.B. and Fujimoto, V.Y. (2008) Fibroids and Reproductive Outcomes: A Systematic Literature Review from Conception to Delivery. American Journal of Obstetrics & Gynecology, 198, 357-366.
https://doi.org/10.1016/j.ajog.2007.12.039
[18]
Kellal, I., Haddouchi, N.E., Lecuyer, A.I., Body, G., Perrotin, F. and Marret, H. (2010) Gros-Sesse et Fibrome: Quelles Complications? Gynécologie Obstétrique & Fertilité, 38, 569-575. https://doi.org/10.1016/j.gyobfe.2010.08.001
